Beam Therapeutics, Inc. (BEAM)

29.64 +0.18 (+0.61%) USD  |  NASDAQ  |  Sep 04, 16:00
30.30 +0.66 (+2.21%) After-Hours: 18:13
More

Beam Therapeutics Cash and Short Term Investments (Annual) : 1.245B for Dec. 31, 2025

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for BEAM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2017. Start Trial.
Date Value
December 31, 2025 1.245B
December 31, 2024 850.74M
December 31, 2023 1.190B
December 31, 2022 1.078B
December 31, 2021 965.65M
Date Value
December 31, 2020 299.67M
December 31, 2019 91.85M
December 31, 2018 146.44M
December 31, 2017 1.901M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Twist Bioscience Corp. 232.43M
Prime Medicine, Inc. 177.68M
Intellia Therapeutics, Inc. 449.88M
Sana Biotechnology, Inc. 142.58M
Revolution Medicines, Inc. 2.026B